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598a Wednesday, March 4, 2009loop undergoes a large conformational change. It was our aim to develop a new
fluorescence-based kinase binding assay which could sense this conformational
switch and screen for new allosteric kinase inhibitors.
We used crystal structures of p38a (active and inactive) to identify positions in
the activation loop which undergo significant movement and could be mutated
into Cys for the subsequent attachment of environmentally-sensitive fluoro-
phores. Other solvent-exposed Cys were mutated into Ser to minimize non-
specific labeling. Using acrylodan-labeled p38a, we developed the first
sensitive (Z-factor ¼ 0.85) HTS method for screening inhibitor libraries for
allosteric kinase inhibitors. Endpoint fluorescence measurements can be used
to directly determine the Kd of inhibitor binding. Real-time fluorescence mea-
surements provide information about the kinetics of association and dissocia-
tion.
Adaptation of this approach to other kinases has allowed us to identify weakly
binding scaffolds which bind to the allosteric site. Using structure-based drug
design, we were able to further develop these smaller compounds into more po-
tent kinase inhibitors (Kd ¼ low nM). These new tight binding compounds
have also become powerful tools for identifying which kinases can and cannot
be inhibited allosterically, a critical question which remains to be answered in
the kinase field.
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ATP conversion to ADP is a central process in all living organisms and is cat-
alyzed by a vast number of different enzymes. The energy generated can drive
metabolic processes, directed transport, force-generation and movement as
well as signal transduction and regulation. While ATPases generate ADP and
free phosphate, kinases transfer the terminal phosphate of ATP to a wide vari-
ety of substrates, from metabolic intermediates to proteins, so controlling their
activity. Hence, assays to monitor ADP concentrations have wide applications
in biochemical and biomedical research, ranging from detailed understanding
of mechanochemical coupling in motor proteins to screening for ATPase and
kinase inhibitors.
Fluorescent, protein-based biosensors have been reported for a number of
biomolecules such as sugars, amino acids, metal ions and phosphate. This ap-
proach takes advantage of the highly specific interaction of a protein with the
target molecule, which can be coupled to an optical signal by attaching fluoro-
phores in suitable positions on the protein. Following this strategy, we have
developed sensors for ADP based on fluorescently labelled mutants of the bac-
terial actin homologue ParM. We report two ADP sensors with distinct optical
properties and ADP-binding characteristics, suitable for different types of
in vitro assays. A coumarin-labeled variant binds ADP tightly and fast and
can detect submicromolar concentrations of ADP. The sensor is particularly
useful for mechanistic studies, where high sensitivity and high time resolution
are required. The second variant is labeled with two rhodamine dyes, exploiting
the stacking of rhodamines to generate a signal change. This variant has a more
photostable fluorophore, higher wavelength excitation and lower ADP binding
affinity, making it more suitable for high-throughput screening assays.
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Human Immunodeficiency Virus Type-1 (HIV-1) protease recognizes at least
ten cleavage sites as its natural substrates. There is little sequence homology
between these substrates and they are asymmetric around the cleavage site in
both charge and size distribution. Thus, understanding of the molecular deter-
minants of substrate recognition is challenging as well as of great importance in
design of effective drugs. The protease-substrate complex crystal structures in-
dicate that substrates occupy a remarkable uniform region within the binding
site, which has been termed as the substrate envelope. Nevertheless, protein ac-
tivity is intimately related to the dynamics, from local to global motion of the
structure. To this end, an elaborated analysis on both structural and dynamic
features of seven HIV-1 protease-substrate complexes have been carried out
by molecular dynamics (MD) simulations. Conformations of the complex
structures in time were analyzed with respect to the interaction of substrate
with protease in terms of the substrate volume, changes in van der Waals
contacts between the two, and dynamics of both substrate and protease. Co-
evolution of substrate peptides with the drug-resistant protease variants was
also analyzed. Similar analysis to those in wild-type complex structures weredone for MD simulations for p1-p6 substrates (wild-type and LP1’F) in
complex with protease variants (D30N, N88D, and D30N/N88D). The substrate
recognition was observed to be an interdependent event and the recognition
mechanism may not be the same for all natural substrates. The dynamic sub-
strate envelope was found to be smaller than the crystal structures suggest.
The substrate recognition is altered when there is drug resistance and this alter-
ation is compensated by co-evolution. The results reveal that conservation of
the peptide conformational preferences and dynamic behavior of the complex
structure appears to be important for substrate recognition.
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Conformational memories (CM) is a Monte Carlo/simulated annealing method
that efficiently searches the torsional conformational space of flexible mole-
cules.1 This method has been recently expanded to include variable bond an-
gles.2 We report the application of CM to ligand/protein docking via the study
of a GP-41 7mer, ELDKWAS, bound to the HIV-1 neutralizing antibody 2F5
(PDB ID: 1TJG).3 Crucial cavity bound waters were determined using MMC
and compared to the 1TJG structure.4 CM was initiated with the peptide 53
A˚ above the protein and brought to the surface in 18 steps using 0.25 kcal/
mol planar and 0.05 kcal/mol cylindrical restraints. At each position,
200,000 MC steps were performed with the temperature annealed from
3000K to 310K. In order to account for electrostatic screening in aqueous so-
lutions we employed a distance dependent, non-linear (sigmoidal) screened
Coulomb potential.5 Final system energies were calculated with a constant di-
electric of 1.0 or with the GB/SA solvent model for water. The GB/SA model
was found to yield better results with the identification of the native energy fun-
nel for the peptide.6 The lowest energy structure identified had an RMSD
(backbone atoms) less than a 1.5 A˚ compared to the peptide conformation in
the 1TJG structure. [Support: NIH DA03934 and DA021358]
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Protein-protein interactions are the basis of cellular functions. Although
computational methods have been developed to identify interface sites of pro-
tein-protein interaction, this remains a challenging task because of the compli-
cations such as conformation change and multiple binding partners. We
develop a novel interface prediction method by incorporating information
from unbound structures of both binding partners. Proteins are represented
by alpha shape and the geometric characteristics of the surfaces are used to gen-
erate surface patches dynamically. Statistical interface potentials derived from
the protein-protein interaction dataset are used to discriminate candidate inter-
faces. Protein flexibility, interface collision, and solvent accessible area are in-
tegrated in our method to model the binding process more realistically. Our new
method can create surface patches very close to the native interface. Compared
to the prediction results of the state-of-art meta method that combined several
interface predictors, our method gives similar performance on the protein-
protein interaction of Benchmark dataset, and gives better performance on
more challenging targets from the CAPRI (community wide protein-protein
docking competition). Furthermore, our method overcomes the limitations of
existing methods and can predict multiple interfaces on proteins with multiple
binding partners.
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Molecular docking is a key tool for studying protein-ligand or protein-protein
interactions and for designing new drugs. Majority of the current binding/dock-
ing methods attempt to predict the bound ligand by keeping the protein (recep-
tor) fixed and moving the target ligand around the binding site while
